Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus initiation to reduce new squamous cell carcinoma after renal transplantation
2012-005481-35Phase 4Terminated
- Sponsor
- Akademiska sjukhuset
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in squamous cell carcinoma (SCC), cutaneous malignancy, sponsored by Akademiska sjukhuset. Started Sep 2013; status: terminated.
02
Drugs
everolimus
03
Conditions
squamous cell carcinoma (SCC)cutaneous malignancy
Beyond the preview
Go deeper on 2012-005481-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005481-35.